Literature DB >> 12845754

Restrictive effect of puerarin on myocardial infarct area in dogs and its possible mechanism.

Q Liu1, Z Lu, L Wang.   

Abstract

To evaluate the protective effect of puerarin on ischemic myocardium in dogs with acute myocardial infarction (AMI) and to reveal its possible mechanism, 10 dogs were randomly divided into puerarin group (group G) and control group (group C). AMI model was established in all dogs. Puerarin or saline was administered over a period of 21 days. Coronary angiography was performed before and after ligation of coronary artery. Eight hemorheological parameters were examined before and 22 days after the operation. The infarct area and vessel density of myocardium were assessed. The infarct area in group G was smaller than that in group C. Angiography 2 h and 22 d after ligation of coronary artery revealed significant augmentation of collateral vessels in group G as compared with control group. The platelet aggregation and the blood viscosity were increased during AMI when compared with control phase, and the increased indexes during AMI would be inhibited when puerarin were given. Capillaries and distribution vessel density in ischemic zone on day 22 showed statistically significant augmentation in group G as compared with control group. Puerarin might improve the opening and formation of coronary collateral circulation, and might inhibit the increase of platelet aggregation and the blood viscosity during AMI, and thereby improve microcirculation and restrict myocardial infarct area.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12845754     DOI: 10.1007/bf02887673

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  3 in total

1.  Puerarin beta-adrenergic receptor blocking effect.

Authors:  X R Lu; E Gao; L Z Xu; H Z Li; B Kang; W N Chen; S M Chen; X S Chai
Journal:  Chin Med J (Engl)       Date:  1987-01       Impact factor: 2.628

Review 2.  Recent insights into coronary collateral circulation.

Authors:  S Sasayama; M Fujita
Journal:  Circulation       Date:  1992-03       Impact factor: 29.690

3.  Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia.

Authors:  S Takeshita; L Q Pu; L A Stein; A D Sniderman; S Bunting; N Ferrara; J M Isner; J F Symes
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

  3 in total
  7 in total

1.  The study on the entrapment efficiency and in vitro release of puerarin submicron emulsion.

Authors:  Peng-Fei Yue; Xiu-Yun Lu; Zeng-Zhu Zhang; Hai-Long Yuan; Wei-Feng Zhu; Qin Zheng; Ming Yang
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

2.  Puerarin inhibits cardiac fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in myocardial infarction mice.

Authors:  Zhiwen Tao; Yingbin Ge; Ningtian Zhou; Yunle Wang; Weili Cheng; Zhijian Yang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

3.  NMR studies on puerarin and its interaction with beta-cyclodextrin.

Authors:  Rui Zhao; Tianwei Tan; Corine Sandström
Journal:  J Biol Phys       Date:  2011-04-19       Impact factor: 1.365

Review 4.  Updates on the clinical evidenced herb-warfarin interactions.

Authors:  Beikang Ge; Zhen Zhang; Zhong Zuo
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-18       Impact factor: 2.629

5.  Mediation of Endogenous β-Endorphin in the Plasma Glucose-Lowering Action of Herbal Products Observed in Type 1-Like Diabetic Rats.

Authors:  I M Liu; J T Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629

6.  Oral Bioavailability and Lymphatic Transport of Pueraria Flavone-Loaded Self-Emulsifying Drug-Delivery Systems Containing Sodium Taurocholate in Rats.

Authors:  Jin Qiao; Danyang Ji; Shilin Sun; Guangyuan Zhang; Xin Liu; Bingxue Sun; Qingxiang Guan
Journal:  Pharmaceutics       Date:  2018-09-05       Impact factor: 6.321

Review 7.  Effects of Puerarin on the Prevention and Treatment of Cardiovascular Diseases.

Authors:  Yan-Xi Zhou; Hong Zhang; Cheng Peng
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.